SAN RAFAEL, Calif., Nov. 30, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a virtual R&D Day beginning at 8:00am PT/11:00am ET today, Tuesday, November 30, 2021. BioMarin management and external experts will provide an update to the investment community on the Company's earlier-stage development portfolio, which is focused on translating genetic discoveries into transformative medicines.
Video Webcast and Live Q&A
Interested parties may access the video presentation that will include audio and slides of the presentations via YouTube using this link: https://youtu.be/05iCxYehS-c. A replay of the meeting will be archived on BioMarin's IR web site.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.
BioMarin® is a registered trademark of BioMarin Pharmaceutical Inc.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.
